Literature DB >> 8136335

Botulinum toxin treatment of bilateral masseteric hypertrophy.

A G Smyth1.   

Abstract

Botulinum toxin is a new and innovative method of treating bilateral masseteric hypertrophy which offers many advantages over conventional surgical treatment. Experience gained through the successful use of this drug when given as an intramuscular injection is reported. No significant side-effects have occurred and this technique is recommended for the routine treatment of masseteric hypertrophy.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8136335     DOI： 10.1016/0266-4356(94)90169-4

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN： 0266-4356            Impact factor:   1.651


  14 in total

1.  [Chemodenervation with botulinumtoxin in masseteric hypertrophy].

Authors:  R A Mischkowski; M Siessegger; F Lazar; J E Zöller
Journal:  Mund Kiefer Gesichtschir       Date:  2005-03

Review 2.  Botulinum toxin for masseter hypertrophy.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2013-09-09

3.  Botox Therapy for Hypertrophy of the Masseter Muscle Causes a Compensatory Increase of Stiffness of Other Muscles of Masticatory Apparatus.

Authors:  Dorota Mierzwa; Cyprian Olchowy; Anna Olchowy; Izabela Nawrot-Hadzik; Paweł Dąbrowski; Sławomir Chobotow; Kinga Grzech-Leśniak; Paweł Kubasiewicz-Ross; Marzena Dominiak
Journal:  Life (Basel)       Date:  2022-06-06

4.  Electromyographic activity of the masseter muscle after radiofrequency therapy in an animal model.

Authors:  Jin-Won Jung; Kyung-Ho Song; Youngjoon Chee; Yong-Wook Jang; An-Sook Kim; Seong-Gon Kim
Journal:  Oral Maxillofac Surg       Date:  2010-03

Review 5.  New Management in Bilateral Masseter Muscle Hypertrophy.

Authors:  Gabriele Bocchialini; Andrea Castellani; Stefano Negrini; Alessandro Rossi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-11-01

6.  Ultrastructural evaluation of intramuscular applied botulinum toxin type A in striated muscles of rats.

Authors:  H Kocaelli; M Yaltirik; M Ayhan; F Aktar; B Atalay; S Yalcin
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

7.  Idiopathic masseter muscle hypertrophy.

Authors:  Biruktawit Kebede; Shimalis Megersa
Journal:  Ethiop J Health Sci       Date:  2011-11

Review 8.  Botulinum toxin: The Midas touch.

Authors:  P S Shilpa; Rachna Kaul; Nishat Sultana; Suraksha Bhat
Journal:  J Nat Sci Biol Med       Date:  2014-01

9.  Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.

Authors:  Fernanda Homem de Mello de Souza Klein; Fabiane Mulinari Brenner; Maurício Shigeru Sato; Fernanda Manfron Batista Rosas Robert; Karin Adriane Helmer
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

10.  Combination of Medical and Surgical Treatments for Masseter Hypertrophy.

Authors:  M Ayhan; Sabri Cemil İşler; C Kasapoglu
Journal:  Case Rep Dent       Date:  2018-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.